• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model." [Eur. J. Pharm. Biopharm. 94 (2015) 521-531].

作者信息

Alibolandi Mona, Sadeghi Fatemeh, Abnous Khalil, Atyabi Fatemeh, Ramezani Mohammad, Hadizadeh Farzin

机构信息

Biotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

Targeted Drug Delivery Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Scienecs, Mashhad, Iran.

出版信息

Eur J Pharm Biopharm. 2019 Sep;142:540. doi: 10.1016/j.ejpb.2019.02.005. Epub 2019 Aug 8.

DOI:10.1016/j.ejpb.2019.02.005
PMID:31470967
Abstract
摘要

相似文献

1
Corrigendum to "The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model." [Eur. J. Pharm. Biopharm. 94 (2015) 521-531].
Eur J Pharm Biopharm. 2019 Sep;142:540. doi: 10.1016/j.ejpb.2019.02.005. Epub 2019 Aug 8.
2
The chemotherapeutic potential of doxorubicin-loaded PEG-b-PLGA nanopolymersomes in mouse breast cancer model.载有阿霉素的聚乙二醇-聚乳酸-羟基乙酸共聚物纳米聚合物囊泡在小鼠乳腺癌模型中的化疗潜力。
Eur J Pharm Biopharm. 2015 Aug;94:521-31. doi: 10.1016/j.ejpb.2015.07.005. Epub 2015 Jul 10.
3
Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.上皮细胞黏附分子适体偶联的 PEG-PLGA 纳米聚合物囊泡用于体外靶向递送至人乳腺癌腺癌细胞系的多柔比星。
Int J Pharm. 2015 Feb 1;479(1):241-51. doi: 10.1016/j.ijpharm.2014.12.035. Epub 2014 Dec 18.
4
Corrigendum to "Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection" [Eur. J. Pharm. Biopharm. 111 (2017) 33-43].
Eur J Pharm Biopharm. 2019 Dec;145:96-97. doi: 10.1016/j.ejpb.2019.10.006. Epub 2019 Nov 7.
5
Corrigendum to "Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery" [Eur. J. Pharm. Biopharm. 129 (2018) 257-266].
Eur J Pharm Biopharm. 2018 Oct;131:151. doi: 10.1016/j.ejpb.2018.08.005. Epub 2018 Aug 20.
6
Corrigendum to "Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis" [Eur. J. Pharm. Biopharm. 93 (2015) 183-195].
Eur J Pharm Biopharm. 2021 Apr;161:1-3. doi: 10.1016/j.ejpb.2021.01.019. Epub 2021 Feb 9.
7
Corrigendum to "Andrographolide-loaded nanoparticles for brain delivery: Formulation, characterisation and in vitro permeability using hCMEC/D3 cell line" [Eur. J. Pharm. Biopharm. 119 (2017) 253-263].《用于脑递送的穿心莲内酯纳米粒：使用hCMEC/D3细胞系的制剂、表征及体外通透性》的勘误 [《欧洲药理学与生物药剂学杂志》119 (2017) 253 - 263]
Eur J Pharm Biopharm. 2017 Nov;120:146. doi: 10.1016/j.ejpb.2017.09.010. Epub 2017 Sep 23.
8
Corrigendum to "Sequentially dynamic polymeric micelles with detachable PEGylation for enhanced chemotherapeutic efficacy" [Eur. J. Pharm. Biopharm. 145 (2019) 54-64].《用于增强化疗疗效的具有可分离聚乙二醇化的顺序动态聚合物胶束》的勘误[《欧洲药学与生物药剂学杂志》145 (2019) 54 - 64]
Eur J Pharm Biopharm. 2024 May;198:114268. doi: 10.1016/j.ejpb.2024.114268. Epub 2024 Mar 22.
9
Corrigendum to "DEAE-Dextran coated paclitaxel nanoparticles act as multifunctional nano system for intranuclear delivery to triple negative breast cancer through VEGF and NOTCH1 inhibition" [Eur. J. Pharm. Biopharm. 122 (2018) 37-48].
Eur J Pharm Biopharm. 2024 Feb;195:114172. doi: 10.1016/j.ejpb.2023.114172. Epub 2023 Dec 22.
10
Corrigendum to "Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system" [Eur. J. Pharm. Biopharm. 73 (2009) 43-49].
Eur J Pharm Biopharm. 2019 Sep;142:541. doi: 10.1016/j.ejpb.2019.08.002. Epub 2019 Aug 8.